Consumables Segment to Hold Major Drug Abuse Testing Market Share During 2020–2027
According to our new research study on "Drug Abuse Testing Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Product, Sample Type, and End User," the market was valued at US$ 6,022.57 million in 2019 and is expected to reach US$ 9,393.17 million by 2027; it is estimated to record a CAGR of 5.7% from 2020 to 2027. The report highlights the trends and drivers prevailing in the market.
Based on product, the drug abuse testing market is segmented rapid testing devices, analyzers, and consumables. In 2019, consumables segment held the largest share of the market. Moreover, the rapid testing devices segment is expected to grow at the fastest rate during the coming year. The consumables used in drug abuse testing include reagents, kits, and fluid collection devices. The reagents and controls used in an analyzer also play an essential role in the accuracy of substance abuse tests. Consumable testing devices are used to conduct oral fluid drug testing on-site for self-analysis, Fluid collection devices provide a simple, non-invasive, observed collection for drug testing. Hence, the use of a fluid collection device helps in avoiding risks associated with adulteration and dilution. Since consumables form an essential part of drug abuse testing, its demand is expected to grow at a considerable pace during the future years.
Global Drug Abuse Testing Market, By Regions, 2018 (%)
Drug Abuse Testing Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Product (Rapid Testing Devices, Analyzers, and Consumables), Sample Type (Blood, Urine, Saliva, and Other Sample Types), and End User (Hospitals, Diagnostic Laboratories, and Forensic Laboratories)
Drug Abuse Testing Market to Grow at a CAGR of 5.7% to reach US$ 9,393.17 Million from 2019 to 2027
Download Free Sample
Based on sample type, the drug abuse testing market is segmented into blood, urine, saliva, and other sample types. In 2019, urine segment held the largest share of the market. In addition, the segment is expected to grow at the fastest rate during the coming year. The urine can contain several different clues about how the body is doing, and urine tells a lot about health. Testing the urine is known as urinalysis, which is used to diagnose a disease or to screen for health problems. For drug abuse testing, urine is the most preferred sample for the detection of drugs or alcohol. Urine screens are the most preferred methods of drug testing. Urinalysis for drug abuse testing is generally painless, cost-effective, easy, and quick. They can also detect both illegal and prescription drugs. The urine drug test usually screens for substances such as amphetamines, methamphetamines, and benzodiazepines, among others.
Based on end user, the global drug abuse testing market is divided into hospitals, diagnostic laboratories, and forensic laboratories. In 2019, hospitals segment held the largest share of the market. Moreover, the segment is expected to grow at the fastest rate during the coming year. Hospitals complement the effectiveness of many other parts of the health system, providing continuous availability of services for acute and complex conditions. Hospitals are a vital component of health system development. Hospital and clinic dentistry offer oral health care to patients with a range of medical and psychosocial considerations. Hospitals as key actors in health systems face growing pressures, especially cost-cutting, and search for cost-effective ways to resources management. Hospitals in the United States conduct tests for drug abuse. For instance, Cincinnati hospitals use urine immunoassays for conducting initial screening, followed by mass spectrometry to authenticate results, as per Wexelblatt. The hospital’s Children’s mass spectrometry laboratory screens almost 47 drugs of abuse in a sample of urine in a 6-minute analysis. Hence, the reliability, as well as advanced healthcare facilities in hospital settings, is expected to fuel growth of the segment during the forecast period.
Redwood Toxicology Laboratory (Abbott), F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc, OraSure Technologies, Inc., UCP Biosciences, MEDACX Ltd., Beckman Coulter, Inc. (Danaher), Alcolizer Pty Ltd., Wondfo, DRÄGERWERK AG & CO. KGAA, American Screening Corporation, Inc, Mercedes Medical, Alfa Scientific Designs, Inc., Express Diagnostics Int'l, Inc., Omega Laboratories, Inc. and Laboratorio Sodré are among the several players engaged in addressing the growing demands for drug abuse testing.
The report segments the drug abuse testing market as follows:
Based on product, the drug abuse testing market is segmented rapid testing devices, analyzers, and consumables. Based on sample type, the drug abuse testing market is segmented into blood, urine, saliva, and other sample types. Based on end user, the global drug abuse testing market is divided into hospitals, diagnostic laboratories, and forensic laboratories. Based on geography, the drug abuse testing market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, the Netherlands, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, Thailand, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com